Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 1
2013 1
2014 3
2015 1
2017 3
2018 1
2019 5
2020 2
2021 5
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data.
Nadeau SA, Vaughan TG, Beckmann C, Topolsky I, Chen C, Hodcroft E, Schär T, Nissen I, Santacroce N, Burcklen E, Ferreira P, Jablonski KP, Posada-Céspedes S, Capece V, Seidel S, Santamaria de Souza N, Martinez-Gomez JM, Cheng P, Bosshard PP, Levesque MP, Kufner V, Schmutz S, Zaheri M, Huber M, Trkola A, Cordey S, Laubscher F, Gonçalves AR, Aeby S, Pillonel T, Jacot D, Bertelli C, Greub G, Leuzinger K, Stange M, Mari A, Roloff T, Seth-Smith H, Hirsch HH, Egli A, Redondo M, Kobel O, Noppen C, du Plessis L, Beerenwinkel N, Neher RA, Beisel C, Stadler T. Nadeau SA, et al. Among authors: kufner v. Sci Transl Med. 2023 Jan 25;15(680):eabn7979. doi: 10.1126/scitranslmed.abn7979. Epub 2023 Jan 25. Sci Transl Med. 2023. PMID: 36346321 Free PMC article.
The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.
Vukicevic S, Oppermann H, Verbanac D, Jankolija M, Popek I, Curak J, Brkljacic J, Pauk M, Erjavec I, Francetic I, Dumic-Cule I, Jelic M, Durdevic D, Vlahovic T, Novak R, Kufner V, Bordukalo Niksic T, Kozlovic M, Banic Tomisic Z, Bubic-Spoljar J, Bastalic I, Vikic-Topic S, Peric M, Pecina M, Grgurevic L. Vukicevic S, et al. Among authors: kufner v. Int Orthop. 2014 Mar;38(3):635-47. doi: 10.1007/s00264-013-2201-1. Epub 2013 Dec 19. Int Orthop. 2014. PMID: 24352822 Free PMC article. Review.
Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland.
Wolfensberger A, Kufner V, Zaheri M, Zeeb M, Nortes I, Schreiber PW, Vazquez M, Schärer V, Scheier T, Schmutz S, Probst E, Saleschus D, Huber M, Rampini SK, Zingg W. Wolfensberger A, et al. Among authors: kufner v. Emerg Infect Dis. 2022 Oct;28(10):2087-2090. doi: 10.3201/eid2810.220321. Epub 2022 Sep 1. Emerg Infect Dis. 2022. PMID: 36048771 Free PMC article.
Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction.
Vukicevic S, Colliva A, Kufner V, Martinelli V, Moimas S, Vodret S, Rumenovic V, Milosevic M, Brkljacic B, Delic-Brkljacic D, Correa R, Giacca M, Maglione M, Bordukalo-Niksic T, Dumic-Cule I, Zacchigna S. Vukicevic S, et al. Among authors: kufner v. Nat Commun. 2022 Jan 10;13(1):81. doi: 10.1038/s41467-021-27622-9. Nat Commun. 2022. PMID: 35013172 Free PMC article.
External Quality Assessment of SARS-CoV-2 Sequencing: an ESGMD-SSM Pilot Trial across 15 European Laboratories.
Wegner F, Roloff T, Huber M, Cordey S, Ramette A, Gerth Y, Bertelli C, Stange M, Seth-Smith HMB, Mari A, Leuzinger K, Cerutti L, Harshman K, Xenarios I, Le Mercier P, Bittel P, Neuenschwander S, Opota O, Fuchs J, Panning M, Michel C, Hallin M, Demuyser T, De Mendonca R, Savelkoul P, Dingemans J, van der Veer B, Boers SA, Claas ECJ, Coolen JPM, Melchers WJG, Gunell M, Kallonen T, Vuorinen T, Hakanen AJ, Bernhoff E, Hetland MAK, Golan Berman H, Adar S, Moran-Gilad J, Wolf DG, Leib SL, Nolte O, Kaiser L, Schmutz S, Kufner V, Zaheri M, Trkola A, Aamot HV, Hirsch HH, Greub G, Egli A. Wegner F, et al. Among authors: kufner v. J Clin Microbiol. 2022 Jan 19;60(1):e0169821. doi: 10.1128/JCM.01698-21. Epub 2021 Nov 10. J Clin Microbiol. 2022. PMID: 34757834 Free PMC article.
How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effort.
Wegner F, Cabrera-Gil B, Tanguy A, Beckmann C, Beerenwinkel N, Bertelli C, Carrara M, Cerutti L, Chen C, Cordey S, Dumoulin A, du Plessis L, Friedli M, Gerth Y, Greub G, Härri A, Hirsch H, Howald C, Huber M, Imhof A, Kaiser L, Kufner V, Leib SL, Leuzinger K, Lleshi E, Martinetti G, Mäusezahl M, Moraz M, Neher R, Nolte O, Ramette A, Redondo M, Risch L, Rohner L, Roloff T, Schläepfer P, Schneider K, Singer F, Spina V, Stadler T, Studer E, Topolsky I, Trkola A, Walther D, Wohlwend N, Zehnder C, Neves A, Egli A; SPSP consortium. Wegner F, et al. Among authors: kufner v. Microbiol Spectr. 2024 Mar 18:e0362823. doi: 10.1128/spectrum.03628-23. Online ahead of print. Microbiol Spectr. 2024. PMID: 38497714 Free article.
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response.
Marconato M, Abela IA, Hauser A, Schwarzmüller M, Katzensteiner R, Braun DL, Epp S, Audigé A, Weber J, Rusert P, Schindler E, Pasin C, West E, Böni J, Kufner V, Huber M, Zaheri M, Schmutz S, Frey BM, Kouyos RD, Günthard HF, Manz MG, Trkola A. Marconato M, et al. Among authors: kufner v. J Clin Invest. 2022 Jun 15;132(12):e158190. doi: 10.1172/JCI158190. J Clin Invest. 2022. PMID: 35482408 Free PMC article. Clinical Trial.
SARS-CoV-2 variants reveal features critical for replication in primary human cells.
Pohl MO, Busnadiego I, Kufner V, Glas I, Karakus U, Schmutz S, Zaheri M, Abela I, Trkola A, Huber M, Stertz S, Hale BG. Pohl MO, et al. Among authors: kufner v. PLoS Biol. 2021 Mar 24;19(3):e3001006. doi: 10.1371/journal.pbio.3001006. eCollection 2021 Mar. PLoS Biol. 2021. PMID: 33760807 Free PMC article.
27 results